Back

Screening for axon regeneration promoting compounds with human iPSC-derived motor neurons

Ho, T. S.-Y.; Hees, J. T.; Xu, Z.; Kawaguchi, R.; Biscola, N. P.; Taub, D. G.; Chen, K.; Chen, X.; Barrett, L. B.; Cheng, L.; Gabel, C. V.; Havton, L. A.; Geschwind, D. H.; Woolf, C. J.

2021-11-04 neuroscience
10.1101/2021.11.02.466937 bioRxiv
Show abstract

CNS neurons do not regenerate after injury, leading to permanent functional deficits. Although sensory and motor neuron axons do regrow after peripheral nerve injury, functional outcome is limited due to the incomplete and slow regrowth. The lack of human-relevant assays suitable for large-scale drug screens has limited neuro-repair therapy discovery. To address this we developed a phenotypic screening strategy using human induced pluripotent stem cell-derived motor neurons to identify axon-regeneration promoting compounds and targets. The screens involve both re-plating human motor neurons on chondroitin sulfate proteoglycans and measuring regeneration responses to laser axotomy in spot cultures, and from them we identified multiple hits that promote injured axon regrowth. The top hit blebbistatin, a non-muscle myosin II inhibitor, accelerated axon regeneration and functional recovery after sciatic nerve injury in vivo. Human "injury in a dish" assays are suitable, therefore, to screen for therapeutic interventions that can induce or accelerate axon regeneration.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.